Clinical evaluation of the virechana therapy along with an indigenous compound in the management of tamak shwasa (bronchial asthma)

Abstract

Tamak Shwas is a disease of respiratory system where the patient feels difficulty in breathing and it can be correlated to Bronchial Asthma in modern parlance. The disease Shwas as described in Ayurveda is of 5 varieties out of which 3 types of Shwas are stated to be incurable, while one of them doesn’t need any treatment only rest is sufficient, whereas the “Tamak Shwas” has an important place in relation to chikitsa i.e. treatment and management as it is termed as Yapya, i.e. palliative. Tamak Shwas i.e. Bronchial Asthma can be managed with proper therapy. In this context Virechana plays an important role in its management as it is stated “Tamaketu Virechanam” in context to the treatment of Tamak Shwasa. A Study has been carried out to evaluate the effect of Virechana Therapy along with an Indigenous preparation in the management of Tamak Shwasa (Bronchial Asthma). For this an indigenous Compound drug (Shirish, Guduchi and Vasaka) was prepared in the form of Ghan Vati and Virechana Dravya consisting of Guduchi Satva, Triphala Churna and Eranda Taila was advocated in two different groups each consisting of 20 patients. Group A was given only trial drug in a dose of 1gm (two tablets) thrice daily with warm water while patients in Group B were advised to take Virechana Therapy for 7 days prior to trial drug therapy. The effect was compared and found to be encouraging with fewer side effects.

Authors and Affiliations

Dr. Poonam Sharma

Keywords

Related Articles

Comparision of nerve flossing and conventional therapy with only conventional therapy for sciatica

Background Sciatica is one of the most common painful and disabling conditions affecting about 40% of low back pain cases and 1.6% - 43% of adult population annually. Many conventional physiotherapeutic modalities have b...

In-vitro quality evaluation of different products of amoxicillin- clavulanate potassium tablets

Amoxicillin- clavulanate potassium is a broad spectrum antibiotic used in the management of most bacterial infections. World-wide, it is manufactured and marketed by different companies. The innovator brand, Augmentin, i...

Nanoparticle bitter melon (Momordica Charantia L.) as the effort to reduce fasting plasma glucose in menopause women with type 2 diabetic mellitus

Background Clinically, the case of diabetic mellitus type two is the highest case of diabetic mellitus found, accounting there are > 90% of all diabetic cases. One of medicinal treatment of non pharmacology can be done i...

In vitro activity of mupirocin on staphylococcal nasal carriers among health care providers of post operative surgical ward in a tertiary care hospital

Methicillin-resistant Staphylococcus aureus (MRSA) has been associated with considerable morbidity and mortality and is an important public health issue. It is an opportunistic pathogen. The increasing resistance of this...

A case report on management of chronic renal failure

Chronic kidney disease may result from a primary intrinsic kidney disease, from anatomic or obstructive abnormalities, as a secondary complication of another systemic disease, or from acute kidney failure that never full...

Download PDF file
  • EP ID EP419006
  • DOI -
  • Views 34
  • Downloads 0

How To Cite

Dr. Poonam Sharma (2017). Clinical evaluation of the virechana therapy along with an indigenous compound in the management of tamak shwasa (bronchial asthma). International Journal of Allied Medical Sciences and Clinical Research, 5(2), 616-619. https://europub.co.uk/articles/-A-419006